Delta enkephalin analogue [D-Ala(2),D-Leu(5)]enkephalin (DADLE) has been shown to protect dopamine transporters from methamphetamine-induced neurotoxicity. In the present study, we demonstrate that exposure of embryonic ventral mesencephalic cells to DADLE (0.01 g/ml), prior to intrastriatal transplantation, enhanced functional recovery and graft survival in 6-hydroxydopamine-induced hemiparkinsonian rats. At 6 and 8 weeks posttransplantation, animals that received DADLE-treated cell grafts exhibited significantly higher (near normal) spontaneous locomotor behaviors, as well as trends of greater reversal of motor asymmetrical behaviors compared with animals that received nontreated cell grafts. Histological examination revealed that animals transplanted with DADLE-treated cell grafts exhibited about twice the number of surviving tyrosine hydroxylase-immunoreactive grafted neurons compared with those animals that received nontreated cell grafts. These results suggest that DADLE should be considered as an adjunctive agent for neural transplantation therapy in Parkinson's disease.
INTRODUCTION
We have recently demonstrated that intracerebral infusion of delta enkephalin analogue [D-Ala(2),D-Leu(5)]enkephalin (DADLE) has protective and reparative ef-Clinical trials of neural transplantation are now under way for treating neurological disorders such as Parkin-fects on dopamine transporter loss induced by chronic methamphetamine treatment in mice (17, 27, 28) . We also son's disease (PD), Huntington's disease, and stroke (3) . While encouraging results have been reported (3,18,19, have shown that treatment with DADLE enhances in vitro survival of cultured rat fetal dopaminergic neurons 31,33), the implementation of large-scale clinical trials of this therapy has been hampered by relatively poor sur-and protects in vivo against depletion of rat adult dopaminergic neurons (5) . Because of these observed en-vival of grafted cells (only about 5-8%) (14) . Recent laboratory studies have demonstrated several factors that hancing effects of DADLE on the dopaminergic system, we examined in the present study the possible potentiat-may influence graft survival, including the limited window to obtain high cell viability prior to transplantation ing actions of DADLE on intracerebral grafts of dopaminergic neurons (derived from rat fetal ventral mesen-and scarce trophic factors available to the cells following transplantation (13, 22, 26) . A significant drop in cell via-cephalon, VM) using the unilateral 6-hydroxydopamine (6-OHDA) lesion rat model of PD. bility is observed at 48 h after harvesting of fetal tissues (14) , whereas thawing of cryopreserved neurons from cell lines only remain viable over 2 h (2) . Interestingly, novel MATERIALS AND METHODS proteins such as growth/trophic factors and free radical scavengers have been used to enhance fetal cell culture Fetal rat VM cells were harvested from timed pregnant rats (gestation age 14 days old, Sprague-Dawley, and graft viability (7, 16, 20, 25, 32) . Thus, there is potential for adjunctive treatment with trophic factors or free Charles River), following the procedures described elsewhere (12) . Handling of animals followed the NIH radical scavengers as a strategy for augmenting the functional effects of neural transplantation therapy.
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sions of VM cells (20,000 cell/µl) were stored at 4°C (SC), number of stereotypies (NS), stereotypy time (ST), clockwise rotations (CR), and anticlockwise rotations over 3 days in a minimum essential hibernation medium (0.35% glucose in sterile saline) with or without (AR). Data for each variable were collected every hour for 12 consecutive hours (1800 to 0600 h). ANOVAs DADLE (0.01 g/ml). This dosage of DADLE is within the reported range known to provide protection against with Bonferroni's corrected t-tests were used to reveal statistical differences between the two groups on each loss of dopamine transporter induced by chronic methamphetamine (27,28). Trypan blue exclusion method behavioral test. Differences were considered significant at p < 0.05. Values are presented as mean ± SEM. was used to reveal the cell viability of aliquots from each treatment condition. In our preliminary studies, this After the behavioral tests at 8 weeks posttransplantation, the animals were deeply anesthetized with chloral 3-day storage period resulted in a significant drop in the viability of nontreated fetal cells (only about 60% via-hydrate (600 mg/kg, IP) and perfused intracardiacally with 150 ml saline followed by 150 ml of 4% paraform-ble), whereas those cells exposed to DADLE remained greater than 85% viable. The same number of viable aldehyde. The brains were postfixed overnight in 4% paraformaldehyde and subsequently immersed in 20% cells (200,000 in 3 µl HBSS, containing approximately 20,000 dopaminergic neurons) from each treatment con-sucrose in 4% paraformaldehyde and stored at 8°C until sectioning. A vibrotome (Vibroslice, FL) was used to dition was used for transplantation.
The transplant recipients consisted of adult male cut the brain (40-µm sections). Six serial striatal sections (corresponding to sections between 2 mm anterior and 1 Sprague-Dawley rats (350-400 g; Charles River, IN) that were introduced a month earlier to unilateral lesions mm posterior to bregma) were processed for tyrosine hydroxylase (TH) immunohistochemistry. Sections were of the right medial forebrain bundle (4.4 mm posterior to bregma, 1.2 mm lateral to the midline, and 7.8 mm preincubated in 5% blocking serum (normal goat, Jackson ImmunoResearch Laboratories, PA) in 0.1% Triton-below the dura) with 6-OHDA (3 µg/µl, RBI Chemicals, IN). All the animals included in the subsequent trans-X in 0.1 M phosphate-buffered saline (NaPBS) for 60 min, followed by incubation in the primary TH (Eugene plantation procedure displayed at least 210 complete rotations over 30 min when challenged with amphetamine Tech International, NJ, 1:1000 dilution in 0.1 M NaPBS) at room temperature overnight. The sections were re-(5 mg/kg, SC), which is an indication of at least >90% destruction of dopaminergic neurons in the substantia acted with the appropriate biotinylated secondary antibody (1:2000) for 45 min, followed by an avidin-biotin-nigra (29). In addition, these animals had greater than 85% elevated biased swing activity and marked reduc-peroxidase complex system (ABC Elite Vectastain Kit, Vector, Burlingame, CA) for 45 min. Finally, the Vector tion in general spontaneous locomotor activity (Digiscan Activity System; AccuScan, OH), both indices of par-VIP Kit (Vector, Burlingame, CA) was used to visualize the reaction product. The sections were mounted on gel-kinsonian symptoms in the rat (4, 6, 15) . The animals were housed in a temperature-controlled room with nor-atin-coated glass slides, dried overnight, dehydrated in increasing alcohol concentrations, and coverslipped us-mal 12-12-h light-dark cycle. Food and water were freely available in the house cage. Animals were ran-ing Permount mounting solution. The sections were digitized using a PC-based Image Tools computer program. domly assigned to either transplantation of DADLEtreated or nontreated cells (n = 8 per group). Animals During estimation of graft survival, sections were blindcoded and the Abercrombie formula (1) was used to cal-were anesthetized (400 mg/kg chloral hydrate, IP) and placed in the stereotaxic apparatus (Kopf Instruments, culate the total number of grafted TH-ir neurons. Student's t-test was used to compare mean total TH-ir UK) for intrastriatal (1 mm anterior to bregma, 2.5 mm lateral to the midline, and 5.5 mm below the dura) trans-grafted neurons between the two treatment groups. Statistical significance was set at p < 0.05. Values are pre-plantation surgery. The surgical procedures were done under aseptic conditions. Throughout the surgery and sented as mean ± SEM. until recovery, body temperature was kept at 37°C using RESULTS a heating pad.
At 6 and 8 weeks posttransplantation, the animals Although both groups of lesioned animals displayed significant recovery on all three behavioral tests at 6 and were tested again in the amphetamine-induced rotational test, elevated body swing test, and Digiscan spontaneous 8 weeks posttransplantation compared with their baseline performance, ANOVAs revealed significant treat-locomotor test. All tests were done at nighttime. For the Digiscan locomotor test, the following variables were ment effects on the Digiscan activity test of spontaneous locomotor behavior, F(1, 14) = 25.06, p < 0.05, but not measured: horizontal activity (HA), total distance (TD), number of movements (NM), movement time (MT), rest in the other two behavioral tests (Fig. 1 ). Prior to transplantation, all lesioned animals showed significant hypo-time (RT), speed (SP), vertical activity (VA), vertical movements (VM), vertical time (VT), stereotypy counts activity in many of the locomotor parameters as pre-viously observed (6, 15) . At posttransplantation periods, lesioned animals that received DADLE-treated cell grafts exhibited a significantly enhanced improvement in spontaneous locomotor activity at 6 weeks posttransplantation compared with those that received nontreated cell grafts (p < 0.05) (Fig. 1) . Eleven of the 14 locomotor parameters detected by the Digiscan monitors were significantly higher in animals that received DADLEtreated grafts than those that received the nontreated grafts ( Table 1 ). Significant increments (ps < 0.05) were found in the following locomotor variables: horizontal activity, total distance, number of movements, movement time, rest time, vertical activity, vertical movements, vertical time, stereotypy counts, number of stereotypies, and stereotypy time. Only speed and clockwise and anticlockwise rotational behaviors were not altered by treating the grafts with DADLE. These significant differences in locomotor activity between the two groups, however, were not evident (only a trend) at 8 weeks posttransplantation. There were also trends of better recovery from amphetamine-induced rotational behavior and motor asymmetry in lesioned animals that received DADLE-treated cell grafts than lesioned animals that received nontreated cell grafts (Fig. 1 ). Lesioned animals that received DADLE-treated grafts displayed mean total 48 ± 22 rotations for the two test periods, compared with 66 ± 25 rotations exhibited by lesioned animals that received nontreated grafts. Similarly, lesioned animals that received DADLE-treated grafts had lower mean biased swing activity (51 ± 3%) for the two test periods, compared with the motor asymmetry (57 ± 4.5%) displayed by lesioned animals that received nontreated grafts. Histological assessment revealed that there were significantly more surviving grafted TH-ir neurons in the lesioned animals that received DADLE-treated cell grafts (732.5 ± 88.6) than those that received the nontreated cell grafts (380.2 ± 54.0), t(14) = 12.94, p < 0.05 (Fig. 2) . Based on the initial 20,000 dopaminergic neurons that were transplanted, the percentages of graft sur-FACING COLUMN Figure 1 . DADLE enhancement of behavioral recovery induced by fetal dopaminergic grafts. Spontaneous locomotor activity was improved in both DADLE-treated and nontreated cell graft recipients, but was more robust in the DADLE transplanted animals (A). Horizontal activity is used as representative sample of general locomotor behaviors of the animals; 11 other locomotor variables showed significant increments in animals that received DADLE-treated grafts. Trends of DADLE-induced enhancement of functional recovery were noted in amphetamine-induced rotational test (B) and elevated body swing test (C). *Significance at p < 0.05. vival for treated and nontreated cell grafts were 3.7% cell grafts may have some long-term effects. For examand 1.9%, respectively. ple, it is possible that an ongoing degenerative process persists even after the transplantation procedure and this DISCUSSION would compromise the survival of the grafted neurons. The present study demonstrates that supplementation In this case, a higher number of surviving TH-ir neurons of DADLE in the hibernation medium of rat fetal VM may prove advantageous in the long term (7, 23) . cells promoted a generally enhanced behavioral im-
The low percentage yield of surviving TH-ir neurons provement following transplantation of DADLE-treated in the present study compared with previous studies cells in 6-OHDA-lesioned rats. Moreover, DADLE pre- (11, 24) demonstrating at least 10% survival might have treatment of donor cells resulted in a higher number of been affected by storing the cells for 3 days prior to surviving grafted dopaminergic neurons. There were transplantation. Obtaining a high yield of grafted neutrends of better functional recovery in lesioned animals rons derived from primary fetal tissues seems to depend that received DADLE-treated cell grafts than those that on an efficient transplantation procedure (within 48 h received nontreated cell grafts. The absence of consisfollowing harvesting) (14, 30) . While Brundin and coltent significant differences in the behavioral perforleagues (8, 9) have consistently demonstrated high yield mance between the two groups could be due to ceiling of surviving grafts even without nutritive pretreatment, effects of the grafts; however, behavioral testing at early they have also explored techniques to increase graft surposttransplantation periods might reveal robust effects vival (7, 22, 24, 26) . In concert, Dunnett and colleagues of DADLE treatment. The survival of about 200 grafted (30) and several others (5, 13, 14, 20) have noted that the TH-ir neurons is sufficient to promote functional recovmedium used for cell storage affects graft survival. The ery (9) , and beyond 400 surviving grafted TH-ir neurons present results showed that with a prolonged storage of do not generally produce enhanced behavioral effects primary fetal cells, the addition of DADLE in the hiber- (8) . This would suggest that because both treatment nation medium could exert survival-promoting effects as groups in the present study had more than the required revealed by higher number of TH-ir neurons in treated 200 surviving TH-ir neurons, the DADLE-enhanced surcells than nontreated cells following transplantation. vival of grafted TH-ir neurons might not translate to a
We have recently demonstrated that DADLE is a posignificantly higher degree of functional recovery than tent free radical scavenger in that it inhibits accumulathat produced by the nontreated cell grafts. Nevertheless, this high number of TH-ir neurons in DADLE-treated tions of superoxide anions and hydroxyl radicals in vitro (27,28) and it blocks the methamphetamine-induced c-fos mRNA increase in mouse striatum (16) . Furthermore, exposure of cultured rat fetal VM cells or systemic injection of DADLE prior to 6-OHDA intoxication promotes survival of dopaminergic neurons (5) . DADLE was originally discovered as a "hibernation-induction trigger" as it was found to induce hibernation in summer-active ground squirrels (21). Thereafter, DADLE was found to enhance preservation and survival of isolated or transplanted organs (10) . Accordingly, the hibernation-induction trigger effects of DADLE might explain the enhanced graft survival even after a prolonged storage of the donor cells. These free radical scavenging and hibernating properties of DADLE make it a valuable supplement factor in the hibernation medium of primary fetal VM cells. The present observations that DADLE pretreatment enhanced functional recovery, coupled with increased graft survival in an animal model of PD, offer an alternative treatment strategy in optimizing the efficacy of neural transplantation therapy.
SUMMARY
We report, for the first time, that adding the delta opioid peptide, DADLE, to the hibernation medium of rat fetal brain dopaminergic cells enhances the survival of these cells following transplantation into the brains of parkinsonian rats. Moreover, the present study shows some enhancement of graft-derived behavioral effects. We propose that DADLE supplementation can increase the efficacy of neural transplantation therapy for Parkinson's disease.
